- Home
- SWZ vs HYFT Comparison
SWZ vs HYFT Comparison
Compare SWZ & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SWZ | HYFT |
|---|---|---|
| Founded | 1986 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.6M | 80.8M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | SWZ | HYFT |
|---|---|---|
| Price | $6.27 | $1.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.2K | ★ 313.2K |
| Earning Date | 01-01-0001 | 12-15-2025 |
| Dividend Yield | ★ 6.59% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,019,110.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $51.71 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 49.46 |
| 52 Week Low | $7.12 | $0.27 |
| 52 Week High | $8.57 | $3.25 |
Technical Indicators
Market Signals| Indicator | SWZ | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 66.78 | N/A |
| Support Level | $6.21 | N/A |
| Resistance Level | $6.30 | N/A |
| Average True Range (ATR) | 0.07 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 87.50 | 0.00 |
Price Performance
Historical ComparisonAbout SWZ Swiss Helvetia Fund Inc. (The)
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The group invests in various sectors such as pharmaceuticals, food and beverage, industrial goods and services, banks, personal and household goods, construction and materials, biotechnology, medical equipment, chemicals, technology, financial services, insurance, Semiconductors, Information Technology, and retail.
About HYFT MindWalk Holdings Corp.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.